China Regulatory Compliance for Life Sciences

Speaker

Instructor: Robert J Russell
Product ID: 702037

Location
  • 8
  • November 2024
    Friday
  • 10:00 AM PT | 01:00 PM ET
    Duration: 90 Min
China’s Life Sciences Compliance webinar will discuss the regulatory structure and requirements for compliance against China’s NMPA regulations for Pharmaceuticals, Medical Devices, Biologics and Combination Products.
LIVE ONLINE TRAINING

November 08, Friday 10:00 AM PT | 01:00 PM ET
Duration: 90 Min

 

$199.00
One Dial-in One Attendee

$899.00
Group-Max. 10 Attendees/Location
(For multiple locations contact Customer Care)

$379.00

$449.00

$249.00
1 Person Unlimited viewing for 6 month info Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training
(For multiple locations contact Customer Care)

$349.00
Downloadable file is for usage in one location only. info Downloadable link along with the materials will be emailed within 2 business days after completion of Live training
(For multiple locations contact Customer Care)

 

 

Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

 

Why Should You Attend:

China has been improving its’ regulatory regime governing the food and pharmaceutical industry in recent years. By promulgating the amended GMP and amending GLP, GCP, GSP and other regulations, China will further align the country with international standards of practice. For manufacturers and distributors of drugs and medical devices in China, as well as importers, it will be important to pay close attention to the pace at which NMPA implements these changes.

This course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products in China. The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies in China. Content will also include descriptions of the methods by which regulators in the NMPA process filings and registrations and what is expected in the authorization and dossier maintenance of licensed products.

Learning Objectives:

This webinar is designed to provide an overview of the regulatory requirements, local challenges and important cultural aspects of working with the lifecycle of Life Science Products (pharmaceuticals, medical devices, biologics, combination products) as an importer into China. It will provide training on:

  • The Regulatory Structure in China.
  • Understanding the specific procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products.
  • How to begin your company's involvement in China: local licenses, personnel and facilities required?
  • Clinical Trials: Why China? NMPA’s requirements, the Application Process, CRO Selection and Start-up.
  • The current key regulations effecting product development and your company's product pipeline.
  • Pricing establishment.
  • Understanding the local concerns and specific challenges in working with Chinese Regulatory Personnel.
  • Understanding the Local Culture: Realistic expectations, timing on reviews, effective strategies for adding China to your company's global market presence.
  • Information necessary for effective dossier preparation and how does one take an already approved CTD dossier and turn it into an acceptable submission package.
  • Strategies for streamlining the registration application process for faster approval.
  • Maintenance of Authorized Products: Variations & Amendments to Licenses

Areas Covered in the Webinar:

  • Country Profile / Healthcare System.
  • Key Country Information.
  • Strategic Considerations: Why China? / Asia Structure / Hub Locations.
  • Governmental & Regulatory Authorities / Agencies / Structure.
  • Company Establishment; Licenses & Key Personnel.
  • Partner Companies / Local Relationship Options.
  • In-Country Operational Considerations; Importance of Local Distributors.
  • Requirements to Conduct Clinical trials / Approvals / GCP.
  • Licensing Products (Innovative Drugs, Generics / Similars, Orphan Drugs, Biologics / Vaccines, Medical Devices).
  • Variations and Amendments to Licenses.
  • GMP and Inspections.
  • Packaging and Labeling.
  • Price Establishment.
  • Reimbursement.
  • Import / Export / Customs Clearance.
  • Taxes / Duties.
  • Advertising & Promotion.
  • Vigilance Reporting / Post-Marketing Requirements.
  • Patents & Trademarks.
  • Local Customs / Cultural Issues / Establishing Business Relationships.
  • Working with Local Agencies / Authorities.
  • Conclusions.

Who Will Benefit:

This course will be beneficial to:

  • Regulatory, Quality, Manufacturing, Global Business Development and General Management personnel whose responsibilities require knowledge of China’s regulatory, quality and import / export requirements.
  • Administrative staff responsible for ensuring compliance with regulatory filings and overall GCP, GMP and GLP compliance requirements.
  • Global business development and general management requiring an understanding of how regulations and compliance issues are culturally handled along with how best to consider China into one’s Global Business Strategy.
Instructor Profile:
Robert J Russell

Robert J Russell
President, RJR Consulting, Inc

Robert J. Russell, (Bob) is the President of RJR Consulting, Inc. RJR Consulting Inc. specializes in understanding global regulatory issues for the pharmaceutical industry. Bob has more than 25 years of experience working with FDA and the Commission on technical issues as they relate to policy development, regulation, clinical trial and the medical device development process.

Prior to entering the consulting field, Mr. Russell was the Global Director of Regulatory Affairs for two Fortune 100 firms. These companies were major raw material suppliers to the pharmaceutical and medical device industry and one a joint-venture parent of a major pharmaceutical division.

Topic Background:

In 2019, the Chinese government established a single drug regulatory authority (The National Medical Products Administration, NMPA) as an important step toward foreign access, because it eliminated the conflicting standards that prevailed among provincial government agencies, centralized the Chinese healthcare regulatory system, and made it more transparent to industry partners. The NMPA (ex-CFDA, ex-SFDA) now oversees all medications. Other former functions of the ministry have been assigned to different government bodies. China has also amended GMP, GLP, GCP, GSP and other regulations to further align the country with international standards of practice (eg. ICH). For manufacturers, distributors and importers of drugs and medical devices into China, changes to standard operating procedures will be required, to ensure compliance with the evolving regime.

  • China’s NMPA continues to make Regulatory Requirement changes at a relatively fast pace. Changes have been proposed and implemented in Drug & Biologics Licensing, Medical Device Registrations, Drug Master Files and have been proposed for Dietary Supplements approved by NMPA. This 90-minute webinar will update you with several of these changes.
Follow us :

 

 

Refund Policy

Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).

 

 

+1-888-717-2436

6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube

 

Copyright © 2023 ComplianceOnline.com MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method